The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic significance of HER2 heterogeneity in early-stage and locally advanced HER2-positive breast cancer.
 
Takaaki Hatano
Stock and Other Ownership Interests - Johnson & Johnson
 
Tomonori Tanei
No Relationships to Disclose
 
Shigeto Seno
No Relationships to Disclose
 
Yoshiaki Sota
No Relationships to Disclose
 
Yuri Kitahara
No Relationships to Disclose
 
Kaori Abe
No Relationships to Disclose
 
Nanae Masunaga
Honoraria - Japan Preventive Medicine; Osaka Medical association
Speakers' Bureau - Daiichi Sankyo; Nippon Kayaku
 
Chieko Mishima
No Relationships to Disclose
 
Masami Tsukabe
No Relationships to Disclose
 
Tetsuhiro Yoshinami
Honoraria - AstraZeneca; Chugai Pharma; Eisai; Kyowa Kirin International; Lilly Japan; MSD; MSD; Pfizer
 
Tomohiro Miyake
Stock and Other Ownership Interests - Abbvie
Speakers' Bureau - AstraZeneca Japan
Research Funding - LinqMed
 
Masafumi Shimoda
Speakers' Bureau - Chugai Pharma; MSD; Pfizer
 
Hideo Matsuda
No Relationships to Disclose
 
Kenzo Shimazu
Speakers' Bureau - AstraZeneca Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Kyowa Kirin; Lilly Japan; MSD; Nippon Kayaku; Pfizer; Sysmex
Research Funding - AstraZeneca Japan; Gilead Sciences; MSD; Ono Yakuhin; Pfizer